Mental Health Channel
Topics & Medications
Quicklinks
Related Channels

Dexmethylphenidate Extended-Release

Dexmethylphenidate extended-release is a prescription drug that is licensed to treat attention deficit hyperactivity disorder (ADHD). While the medicine is a stimulant, it produces a calming effect. In previous studies, dexmethylphenidate extended-release was shown to be effective at treating symptoms of ADHD in both children and adults. Headaches, throat pain, and dry mouth are a few of the common side effects with this medication.

What Is Dexmethylphenidate Extended-Release?

Dexmethylphenidate extended-release (Focalin XR®) is a prescription medication that is used for the treatment of attention deficit hyperactivity disorder (ADHD). Dexmethylphenidate extended-release capsules are specially designed to release half of the medication immediately, and to release the second half of the medication after approximately four hours. As a result, dexmethylphenidate extended-release can be taken just once a day.
 
Because dexmethylphenidate extended-release is a stimulant and is commonly abused, there are special rules for prescribing the medication (see Focalin XR: A Controlled Substance).
 
(Click What Is Dexmethylphenidate Extended-Release Used For? for more information on uses of dexmethylphenidate extended-release, including possible off-label uses.)
 

Who Makes Dexmethylphenidate Extended-Release?

Dexmethylphenidate extended-release is manufactured by Novartis Pharmaceuticals.
 
Substance Abuse in Teens With ADHD

Dexmethylphenidate Extended-Release Info

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.